The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 17, 2021

Filed:

Jun. 12, 2020
Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

Emilio Anthony Emini, Dresher, PA (US);

Wendy Jo Watson, Blue Bell, PA (US);

Avvari Krishna Prasad, Chapel Hill, NC (US);

Mingming Han, Holly Springs, NC (US);

Jin-Hwan Kim, Suffern, NY (US);

Jianxin Gu, Paramus, NJ (US);

Yu-ying Yang, Stamford, CT (US);

Rajesh Kumar Kainthan, Tappan, NY (US);

David Cooper, Monroe, NY (US);

Michael William Pride, Staten Island, NY (US);

Kathrin Ute Jansen, New York, NY (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/09 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61K 47/646 (2017.08); A61K 2039/55505 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention relates to new immunogenic compositions comprising conjughatedcapsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from aserotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.


Find Patent Forward Citations

Loading…